| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |